Investment will advance smart farming technology to empower growers with real-time portable lab data and to support the carbon credit industry with scientifically accurate measurements MONTREAL — ChrysaLabs, a leading innovator at the forefront of soil science, announced today a 15 million Canadian dollar ($11 million) financing round, including investments from Leaps by Bayer, TELUS Ventures and BDC Capital. Existing investors Ecofuel, Emmertech, […]

Transaction to Enable Continued Acquisitions and Growth for USCO SpA and DWK Life Sciences NEW YORK — Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ONE EQUITY PARTNERS CLOSES $1 BILLION CONTINUATION FUND CO-LED BY ALPINVEST PARTNERS AND HARBOURVEST PARTNERS Transaction to Enable Continued Acquisitions and […]

The round was co-led by defy.vc and LDV Partners  SEATTLE — Genemod, a cloud-based workspace collaboration software for biopharma R&D teams, today announced it raised $4.5 million in seed funding, co-led by defy.vc and LDV Partners, with participation from Dolby Family Ventures and Vulcan/Cercano Ventures. In the past year, Genemod has expanded into the biopharma R&D space working […]

Today, we’re thrilled to announce the closing of a $3.7 million seed round, led by Silverton Partners, to revolutionize biological data interpretation and accelerate life sciences discoveries for even more scientific teams around the world. Pluto’s web-based, computational biology platform is designed to empower researchers to analyze, visualize, and intuitively interpret high-dimensional biological data. This […]

New sales, marketing, and product development leaders bring proven track record from high growth enterprise software and procurement organizations BOSTON — Labviva, the AI-driven life sciences procurement platform, today announced the appointment of three new executives to drive key functions. Emily Nault joins Labviva as Senior Vice President, Platform Sales and Commerce, Jonathan Sheffi will […]

Global healthtech investors signal confidence as genomics data technology start-up accelerates growth. CAMBRIDGE, UNITED KINGDOM — Fast-scaling genomic data technology company, Zetta Genomics, has secured £1.9 million in a second seed funding round. New investment comes from existing VC backers as the company configures for Series A funding. The successful close demonstrates ongoing confidence in Zetta Genomics […]

Oberkochen, Germany | ZEISS Group The ZEISS Ventures portfolio continues to grow in the life science space with the investment in ZOMP, an early-stage start-up based in Cambridge, UK, developing a 3D imaging flow cytometer that enables highly accurate quantitative imaging of millions of cells in a single experiment. The ZEISS Ventures portfolio continues to […]

Indee Labs to complete the development and launch of Hydropore RUO and Cell Therapy along with a direct DNA knock-in kit, enabled by BroadOak’s strategic investment and domain expertise. BERKELEY, Calif. — Indee Labs, the developer of Hydropore™ for non-viral intracellular delivery, is partnering with BroadOak Capital Partners, a leading direct investment and advisory firm focused on life science research […]

Strategic investment is closely linked to ZEISS Research Microscopy Solutions and its capabilities in automated, high-resolution imaging and 3D image analysis Oberkochen, Germany |  ZEISS Group ZEISS is investing in life science start-up InSphero to further advance the adoption of 3D microtissues in research and drug development. InSphero AG, a pioneer in 3D spheroid and […]

Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning Boston & Ljubljana, Slovenia – Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are […]